Drug Shortage Report for JAMP-CETIRIZINE

Last updated on 2022-07-19 History
Report ID 149821
Drug Identification Number 02466171
Brand name JAMP-CETIRIZINE
Common or Proper name Cetirizine hydrochloride tablets
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) CETIRIZINE HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code R06AE
ATC description ANTIHISTAMINES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-04
Estimated end date 2022-06-17
Actual end date 2022-06-13
Shortage status Resolved
Updated date 2022-07-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-07-19 English Compare
v10 2022-06-13 French Compare
v9 2022-06-13 English Compare
v8 2022-05-17 French Compare
v7 2022-05-17 English Compare
v6 2022-04-06 French Compare
v5 2022-04-06 English Compare
v4 2022-02-14 French Compare
v3 2022-02-14 English Compare
v2 2021-11-24 French Compare
v1 2021-11-24 English Compare

Showing 1 to 11 of 11